Literature DB >> 24136824

Docosahexaenoic acid impairs the maturation of very low density lipoproteins in rat hepatic cells.

Vatsala Maitin1, Ursula Andreo, Liang Guo, Edward A Fisher.   

Abstract

One mechanism of the lipid-lowering effects of the fish oil n-3 fatty acids [e.g., docosahexaenoic acid (DHA)] in cell and animal models is induced hepatic apolipoprotein B100 (apoB) presecretory degradation. This degradation occurs post-endoplasmic reticulum, but whether DHA induces it before or after intracellular VLDL formation remains unanswered. We found in McA-RH7777 rat hepatic cells that DHA and oleic acid (OA) treatments allowed formation of pre-VLDL particles and their transport to the Golgi, but, in contrast to OA, with DHA pre-VLDL particles failed to quantitatively assemble into fully lipidated (mature) VLDL. This failure required lipid peroxidation and was accompanied by the formation of apoB aggregates (known to be degraded by autophagy). Preventing the exit of proteins from the Golgi blocked the aggregation of apoB but did not restore VLDL maturation, indicating that failure to fully lipidate apoB preceded its aggregation. ApoB autophagic degradation did not appear to require an intermediate step of cytosolic aggresome formation. Taken with other examples in the literature, the results of this study suggest that pre-VLDL particles that are competent to escape endoplasmic reticulum quality control mechanisms but fail to mature in the Golgi remain subject to quality control surveillance late in the secretory pathway.

Entities:  

Keywords:  Golgi; apoB; autophagy; endoplasmic reticulum; lipid peroxidation

Mesh:

Substances:

Year:  2013        PMID: 24136824      PMCID: PMC3927475          DOI: 10.1194/jlr.M043026

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  29 in total

1.  Co-translational interactions of apoprotein B with the ribosome and translocon during lipoprotein assembly or targeting to the proteasome.

Authors:  R Pariyarath; H Wang; J D Aitchison; H N Ginsberg; W J Welch; A E Johnson; E A Fisher
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

2.  Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event.

Authors:  A M Brown; G F Gibbons
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

3.  Fish oil fatty acids impair VLDL assembly and/or secretion by cultured rat hepatocytes.

Authors:  C A Lang; R A Davis
Journal:  J Lipid Res       Date:  1990-11       Impact factor: 5.922

4.  The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways.

Authors:  E A Fisher; M Pan; X Chen; X Wu; H Wang; H Jamil; J D Sparks; K J Williams
Journal:  J Biol Chem       Date:  2001-04-02       Impact factor: 5.157

5.  Apolipoprotein B100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER.

Authors:  Viktoria Gusarova; Jeffrey L Brodsky; Edward A Fisher
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

6.  Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions.

Authors:  Utako Nagaoka; Ken Kim; Nihar Ranjan Jana; Hiroshi Doi; Mieko Maruyama; Kenichi Mitsui; Fumitaka Oyama; Nobuyuki Nukina
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

7.  Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.

Authors:  Meihui Pan; Arthur I Cederbaum; Yuan-Li Zhang; Henry N Ginsberg; Kevin Jon Williams; Edward A Fisher
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Intracellular assembly of very low density lipoproteins containing apolipoprotein B100 in rat hepatoma McA-RH7777 cells.

Authors:  Khai Tran; Gro Thorne-Tjomsland; Cynthia J DeLong; Zheng Cui; Jing Shan; Lynn Burton; James C Jamieson; Zemin Yao
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

9.  The dynamic nature of the Golgi complex.

Authors:  G Griffiths; S D Fuller; R Back; M Hollinshead; S Pfeiffer; K Simons
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

10.  Insulin-stimulated degradation of apolipoprotein B100: roles of class II phosphatidylinositol-3-kinase and autophagy.

Authors:  Ursula Andreo; Liang Guo; Doru V Chirieac; Ana C Tuyama; Emilie Montenont; Jeffrey L Brodsky; Edward A Fisher
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more
  6 in total

Review 1.  Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Authors:  Lynley M Doonan; Edward A Fisher; Jeffrey L Brodsky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-06       Impact factor: 4.698

Review 2.  Regression of Atherosclerosis: The Journey From the Liver to the Plaque and Back.

Authors:  Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-17       Impact factor: 8.311

Review 3.  Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis.

Authors:  Renato Quispe; Abdulhamied Alfaddagh; Brigitte Kazzi; Fawzi Zghyer; Francoise A Marvel; Roger S Blumenthal; Garima Sharma; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2022-04-30       Impact factor: 5.967

Review 4.  Hyperlipoproteinemia type 3: the forgotten phenotype.

Authors:  Paul N Hopkins; Eliot A Brinton; M Nazeem Nanjee
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

5.  Evidence of a DHA Signature in the Lipidome and Metabolome of Human Hepatocytes.

Authors:  Veronica Ghini; Mattia Di Nunzio; Leonardo Tenori; Veronica Valli; Francesca Danesi; Francesco Capozzi; Claudio Luchinat; Alessandra Bordoni
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

6.  Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.

Authors:  Eric Fisher; Elizabeth Lake; Roger S McLeod
Journal:  J Biomed Res       Date:  2014-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.